Table 1.
Characteristics and quality scores of included publications.
| Study | Study type | Number of patients | Age (years) | Tumor size (mm) | Proportion screen-detected | Proportion ILC | Grade | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI | Control | MRI | Control | MRI | Control | MRI | Control | MRI | Control | |||
| Brück [7] | RCT | 50 | 50 | 61 | 61 | 15.0 | 13.0 | 68% | 52% | 0% | 0% | 5 |
| Turnbull [19] | RCT | 816 | 807 | 57.0 | 57.0 | 15∗ | 15∗ | 52% | 52% | 9.0% | 10.0% | 4 |
| Peters [18] | RCT | 74 | 75 | 55.1 | 56.1 | 15 | 15.1 | 100%# | 100%# | NR | NR | 4 |
| Gonzalez [33] | RCT | 220 | 220 | 46 | 46 | NR | NR | 37.7% | 37.7% | NR | NR | 5 |
| Pengel [30] | Comparative | 173 | 176 | 56.8 | 59.2 | 16.9 | 15.7 | 30% | 39% | 16.4% | 14.4% | 7 |
| Bleicher [31] | Comparative | 130 | 447 | 52.5 | 59 | 21 | 21 | 44% | 45% | 15.4% | 11.2% | 7 |
| Miller [26] | Comparative | 219 | 195 | 51.0 | 56.0 | NR± | NR± | 53% | 60% | 12.0% | 7.0% | 8 |
| Weber [25] | Comparative | 120 | 193 | 53.6 | 59.5 | 20.2 | 17.2 | NR | NR | 8.3% | 5.2% | 7 |
| Grady [32] | Comparative | 79 | 105 | 63 | 64 | NR | NR | NR | NR | 14.0% | 9.0% | 7 |
| Petrillo [23] | Comparative | 122 | 124 | 34.8 | 34.7 | NR | NR | NR | NR | 11.5% | 8.9% | 8 |
| Killelea [24] | Comparative | 628 | 817 | 53 | 60 | 16 | 15 | NR | NR | 12% | 11% | 8 |
| Fortune-Greeley [22] | Comparative | 2471 | 17861 | NR | NR | NR | NR | NR | NR | 16.0% | 8.6% | 8 |
| Chandwani [17] | Comparative | 304 | 305 | NR | NR | NR | NR | NR | NR | 11.5% | 9.2% | 7 |
| Arnaout [6] | Comparative | 7824 | 45191 | NR | NR | NR | NR | NR | NR | 10% | 5.9% | 7 |
| Vos [21] | Comparative | 1787 | 3727 | 58 | 63 | NR | NR | 41.3% | 42.6% | 25.1% | 6.2% | 7 |
| Parsyan [20] | Comparative | 307 | 458 | 55.3 | 66.3 | 17.6 | 17.7 | NR | NR | 13.0% | 10.50% | 7 |
| Mann [29] | Comparative | 99 | 168 | 57.0 | 60.0 | 24 | 23 | NR | NR | 100% | 100% | 7 |
| McGhan [28] | Comparative | 72 | 109 | 62.7 | 68.2 | 24.4 | 21.3 | NR | NR | 100% | 100% | 8 |
| Heil [27] | Comparative | 92 | 86 | 57.8 | 63.6 | NR | NR | NR | NR | 100% | 100% | 8 |
RCT: randomized controlled trial; comparative: observational comparative study; age use of median or mean; ILC: invasive lobular cancer; NR: not reported; grade: RCT uses the M-Jadad scale; comparative uses the NOS scale.